Evidence map›Paper›PMID 42227562›Full record

ArticleJournal of the American Chemical Society2026

De Novo Design of Near-Infrared Fluorescence-Activating Proteins.

Yulai Liu, Bernardo A Arús, Kanuj Mishra, Taolin Wang, Kun Zhang, Michael P Luciano, Venu G Bandi, Akaash Kumar, Ziyu Guo, Yun Guan and 15 more

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Non-Covalent Reversibly Photoconvertible Fluorescent Tags for Wash-Free Protein Labeling.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Yulai LiuInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.
Bernardo A ArúsGerman Cancer Research Center (DKFZ), Heidelberg 69120, Germany.ORCID 0000-0001-6132-7793
Kanuj MishraInstitute of Biological and Medical Imaging, Bioengineering Center, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Taolin WangNational Institute of Biological Sciences, Beijing 102206, China.
Kun ZhangNational Institute of Biological Sciences, Beijing 102206, China.
Michael P LucianoChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-1996-1587
Venu G BandiChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.
Akaash KumarMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, U.K.ORCID 0009-0008-0880-1917
Ziyu GuoDepartment of Chemistry, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0002-1200-7328
Yun GuanDepartment of Chemistry, University of Washington, Seattle, Washington 98195, United States.
Matthew J BickInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.
Miaomiao XuInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0002-6901-1459
Jakob LinggHelmholtz Pioneer Campus, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Jessica BaeInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.
Alex KangInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.
Stacey R GerbenInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0003-0313-6248
Asim K BeraInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.
Joshua C VaughanDepartment of Chemistry, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0002-6550-8935
James D MantonMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, U.K.
Emmanuel DeriveryMRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge CB2 0QH, U.K.ORCID 0000-0003-3927-5944
Martin J SchnermannChemical Biology Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, Maryland 21702, United States.ORCID 0000-0002-0503-0116
Andre C StielInstitute of Biological and Medical Imaging, Bioengineering Center, Helmholtz Zentrum München, Neuherberg 85764, Germany.
Oliver T BrunsGerman Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Chunfu XuInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.ORCID 0000-0002-8668-0566
David BakerInstitute for Protein Design and Department of Biochemistry, University of Washington, Seattle, Washington 98195, United States.

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
Howard Hughes Medical InstituteNIGMS NIH HHS P30 GM124165
6 · The paper itself

Abstract

Protein-based fluorescence imaging is a powerful modality for visualizing diverse biological processes. Biological imaging in the near-infrared (NIR, 800-1000 nm) and shortwave infrared (SWIR, 1000-2000 nm) ranges confers a number of photophysical advantages, but remains a challenge in practice due to the dearth of suitable protein probes in these optical windows. To address this limitation, we sought to develop a general approach integrating computational protein design with organic synthesis for creating long-wavelength fluorescence-activating proteins from scratch. We used this approach to de novo design proteins that specifically bind to synthetic merocyanine dyes, forming Schiff base covalent linkages, which when protonated activate fluorescence with large redshifts in both excitation and emission wavelengths. We describe a designed far-red fluorescence-activating protein, MC7BP34, with a brightness greater than that of existing fluorescent proteins in a similar wavelength range, and an NIR design MC9BP81 with excitation at 892 nm and emission extending into the SWIR range with higher contrast and imaging sensitivity in vivo than the previously developed iRFP720 (excitation 672 nm) owing to the reduced tissue autofluorescence at longer wavelengths. Our results are a substantial step toward genetically encodable probes in the SWIR region, and our approach lays the groundwork for the development of NIR biosensors for specific biological applications.

Indexed as

Fluorescent DyesLuminescent ProteinsAnimalsFluorescenceInfrared RaysOptical ImagingFluorescent DyesLuminescent Proteins

Identifiers

PMID42227562
PMCPMC13560888

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.